Ledipasvir/Sofosbuvir Fixed-Dose Combination for 12 or 24 Weeks in Genotype 1 or 4 HCV Infected Adults With Sickle Cell Disease
Clinical trial NCT02301936 · COMPLETED
Trial details
- NCT number
- NCT02301936
- Sponsor
- Gilead Sciences
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2015-03-02
- Primary completion
- 2016-04-18
- Enrollment
- 10
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.